ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance (2014)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; COVAS, DIMAS TADEU - FMRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.bcmd.2014.02.008
- Subjects: LEUCEMIA MIELOIDE AGUDA; APOPTOSE; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Publisher place: Maryland Heights
- Date published: 2014
- Source:
- Título: Blood Cells, Molecules and Diseases
- ISSN: 1079-9796
- Volume/Número/Paginação/Ano: v. 53, n. 1-2, p. 47-55, 2014
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
FERREIRA, A. F. et al. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, v. 53, n. 1-2, p. 47-55, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2014.02.008. Acesso em: 01 abr. 2026. -
APA
Ferreira, A. F., Moura, L. G., Tojal, I., Ambrósio, L., Simões, B. P., Hamerschlak, N., et al. (2014). ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells, Molecules and Diseases, 53( 1-2), 47-55. doi:10.1016/j.bcmd.2014.02.008 -
NLM
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008 -
Vancouver
Ferreira AF, Moura LG, Tojal I, Ambrósio L, Simões BP, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FA de. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance [Internet]. Blood Cells, Molecules and Diseases. 2014 ; 53( 1-2): 47-55.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.bcmd.2014.02.008 - The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms
- Avaliação do perfil de resistência dos lifócitos de pacientes com trombocitemia essencial aos agentes apoptogênicos
- Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in essential thrombocythemia and myelofibrosis
- PRV-1 overexpression in essential thrombocythemia correlates with trail expression
- Apoptomirs expression profile in polycythemia vera patients
- Differential expression of apopttomiRs in myeloproliferative neoplasms. [Carta]
- Differential expression of the flice-inhibitory protein, C-flip, in 'CD34 POT.+'cells in chronic myelogenous leukemia, polycythemia vera and essential trombocythemia
- Deregulated expression of A1, Bcl-2, Bcl-xL, and Mcl-1 antiapoptotic proteins and Bid, Bad, and Bax proapoptotic genes in polycythemia vera patients
- The profile of death receptors, the anti-apoptotic c-flip in cells presents in chronic myeloid leukemia after treatment with tk inhibitors
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
